1. Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda. (December 2021) Authors: Ssengooba, Willy; Komakech, Kevin; Namiiro, Sharon; Byabajungu, Henry; Nalunjogi, Joanitah; Katagira, Winceslaus; Kimuli, Ivan; Joloba, Moses L; Adakun, Susan; Nakiyingi, Lydia; Torrea, Gabriela; Kirenga, Bruce J Journal: Journal of clinical tuberculosis and other mycobacterial diseases Issue: Volume 25(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study. (May 2021) Authors: Baluku, Joseph Baruch; Nakazibwe, Bridget; Naloka, Joshua; Nabwana, Martin; Mwanja, Sarah; Mulwana, Rose; Sempiira, Mike; Nassozi, Sylvia; Babirye, Febronius; Namugenyi, Carol; Ntambi, Samuel; Namiiro, Sharon; Bongomin, Felix; Katuramu, Richard; Andia-Biraro, Irene; Worodria, William Journal: Journal of clinical tuberculosis and other mycobacterial diseases Issue: Volume 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗